AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Hexachlorophene for the Treatment of ParkinsonΓÇÖs Disease and Related Disorders

Technology Benefits: Reduction in endogenous LRRK2 protein levelsReduction in mutant LRRK2 protein levels

Technology Application: therapeutic agent for Parkinson's disease, Crohn's disease, and related disorders

Detailed Technology Description: Mutations in the LRRK2 protein have been linked as one of the causative agents for the pathogenesis of PD and Crohn's disease. Currently, limited options exist for the treatment of these diseases and there is a need to find therapeutic agents that can target LRRK2.In different cell models that overexpress wild-type, mutant, or endogenous LRRK2 protein, treatment with hexachlorophene reduced not only total endogenous LRRK2 but also overexpressed wild-type and mutant LRRK2. Therefore, hexachlorophene has the potential to serve as a treatment option for PD and other related disorders.

*Abstract: The University of South Florida has developed a novel method for the treatment of ParkinsonΓÇÖs Disease (PD) and other related disorders using hexachlorophene.

Country/Region: USA

For more information, please click Here